Oronsaye Report Implementation to End Duplication of Functions — SGF
‘This is the last thing we need’ – Furious Premier League club to speak with PGMOL after defeat
Man loses $1000s buying new truck as DMV alerts him to ‘something odd’ – he wishes he never ignored red flag during sale
UN says firing of adviser who didn’t call Israel genocidal ‘not unusual’
Cancer Vaccines Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, OncoPep, Inc., Mod 12-09-2024 09:34 PM CET | Health & Medicine Press release from: DelveInsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Cancer Vaccines Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cancer Vaccines Market. The Cancer Vaccines Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Cancer Vaccines Pipeline Report: https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Cancer Vaccines treatment therapies with a considerable amount of success over the years. •Cancer Vaccines companies working in the treatment market are Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, OncoPep, Inc., Moderna Therapeutics, Gradalis, Inc., IO Biotech, Dendreon Pharmaceutical s LLC, and others, are developing therapies for the Cancer Vaccines treatment •Emerging Cancer Vaccines therapies in the different phases of clinical trials are- VTP-1100, BP-1209, iNeo-Vac-P01, TG4050, EO2401, ATP128, PVX-410, mRNA-4157, Vigil, IO102-IO103, Sipuleucel-T, and others are expected to have a significant impact on the Cancer Vaccines market in the coming years. •In September 2024, Moderna's mRNA cancer vaccine for solid tumors has shown early potential in interim data from a Phase I study. The mRNA specialist revealed that the vaccine has demonstrated initial signs of an immune response against cancer, prompting the activation of cancer-killing cells. Moderna is scheduled to present the findings from the first-in-human study of mRNA-4359 on September 14 at the European Society of Medical Oncology meeting. •In August 2024, Everest Medicines has launched an investigator-initiated clinical trial (IIT) for its personalized mRNA cancer vaccine, EVM16. The trial, named EVM16CX01, is being carried out at Peking University Cancer Hospital and Fudan University's Cancer Hospital in China. The study aims to assess the tolerability, safety, immunogenicity, and preliminary efficacy of EVM16, both as a standalone treatment and in combination with a PD-1 antibody, in patients with advanced or recurrent solid tumors. Cancer Vaccines Overview The emergence of cancer immunotherapy has significantly transformed cancer treatment, providing renewed optimism for cancer patients. While this therapy has shown remarkable success in certain cases, it is not universally effective, and there are various cancer types that do not exhibit a response to this treatment. Get a Free Sample PDF Report to know more about Cancer Vaccines Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging Cancer Vaccines Drugs Under Different Phases of Clinical Development Include: •VTP-1100: Vaccitech •BP-1209: BrightPath Biotherapeutics •iNeo-Vac-P01: Hangzhou Neoantigen Therapeutics •TG4050: Transgene •EO2401: Enterome •ATP128: Amal Therapeutics •PVX-410: OncoPep, Inc. •mRNA-4157: Moderna Therapeutics •Vigil: Gradalis, Inc. •IO102-IO103: IO Biotech •Sipuleucel-T: Dendreon Pharmaceutical s LLC Cancer Vaccines Route of Administration Cancer Vaccines pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Cancer Vaccines Molecule Type Cancer Vaccines Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Cancer Vaccines Pipeline Therapeutics Assessment •Cancer Vaccines Assessment by Product Type •Cancer Vaccines By Stage and Product Type •Cancer Vaccines Assessment by Route of Administration •Cancer Vaccines By Stage and Route of Administration •Cancer Vaccines Assessment by Molecule Type •Cancer Vaccines by Stage and Molecule Type DelveInsight's Cancer Vaccines Report covers around 300+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Cancer Vaccines product details are provided in the report. Download the Cancer Vaccines pipeline report to learn more about the emerging Cancer Vaccines therapies at: https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Cancer Vaccines Therapeutics Market include: Key companies developing therapies for Cancer Vaccines are - GlaxoSmithKline PLC, Merck & Co. Inc., OSE Immunotherapeutics, Sanofi SA, Dendreon Pharmaceuticals LLC, Moderna Inc., Vaccitech Limited, Anixa Biosciences Inc., AstraZeneca PLC, Bristol Myers Squibb Company, F Hoffmann-La Roche AG (Genentech), Providence Therapeutics, eTheRNA immunotherapies, and others. Cancer Vaccines Pipeline Analysis: The Cancer Vaccines pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Cancer Vaccines with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cancer Vaccines Treatment. •Cancer Vaccines key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Cancer Vaccines Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cancer Vaccines market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Cancer Vaccines drugs and therapies- https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Cancer Vaccines Pipeline Market Drivers •Clinical trial data using personalized cancer vaccines are highly encouraging, cancer vaccines offer clinical benefits to patients with advanced metastatic disease, an attractive approach to synergize with currently available immune therapeutics strategies are some of the important factors that are fueling the Cancer Vaccines Market. Cancer Vaccines Pipeline Market Barriers •However, hurdles in developing appropriate methods to identify, refine and test candidate therapies, high cost associated with the research and other factors are creating obstacles in the Cancer Vaccines Market growth. Scope of Cancer Vaccines Pipeline Drug Insight •Coverage: Global •Key Cancer Vaccines Companies: Vaccitech, BrightPath Biotherapeutics, Hangzhou Neoantigen Therapeutics, Transgene, Enterome, Amal Therapeutics, OncoPep, Inc., Moderna Therapeutics, Gradalis, Inc., IO Biotech, Dendreon Pharmaceutical s LLC, and others •Key Cancer Vaccines Therapies: VTP-1100, BP-1209, iNeo-Vac-P01, TG4050, EO2401, ATP128, PVX-410, mRNA-4157, Vigil, IO102-IO103, Sipuleucel-T, and others •Cancer Vaccines Therapeutic Assessment: Cancer Vaccines current marketed and Cancer Vaccines emerging therapies •Cancer Vaccines Market Dynamics: Cancer Vaccines market drivers and Cancer Vaccines market barriers Request for Sample PDF Report for Cancer Vaccines Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/cancer-vaccines-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Cancer Vaccines Report Introduction 2. Cancer Vaccines Executive Summary 3. Cancer Vaccines Overview 4. Cancer Vaccines- Analytical Perspective In-depth Commercial Assessment 5. Cancer Vaccines Pipeline Therapeutics 6. Cancer Vaccines Late Stage Products (Phase II/III) 7. Cancer Vaccines Mid Stage Products (Phase II) 8. Cancer Vaccines Early Stage Products (Phase I) 9. Cancer Vaccines Preclinical Stage Products 10. Cancer Vaccines Therapeutics Assessment 11. Cancer Vaccines Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Cancer Vaccines Key Companies 14. Cancer Vaccines Key Products 15. Cancer Vaccines Unmet Needs 16 . Cancer Vaccines Market Drivers and Barriers 17. Cancer Vaccines Future Perspectives and Conclusion 18. Cancer Vaccines Analyst Views 19. Appendix 20. About DelveInsight Latest Reports: •Human Papillomavirus Hpv Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market •Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market •Interspinous Spacers Market: https://www.delveinsight.com/report-store/interspinous-spacers-market •Dengue Fever Market: https://www.delveinsight.com/report-store/dengue-fever-market •Chronic Hemodialysis Market: https://www.delveinsight.com/report-store/chronic-hemodialysis-market •Brucellosis Market: https://www.delveinsight.com/report-store/brucellosis-market •Childhood Atropine For Myopia Progression Market: https://www.delveinsight.com/sample-request/childhood-atropine-for-myopia-progression-market Contact Us: Gaurav Bora gbora@delveinsight.com +91-9650213330 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.
Iowa readies for Nebraska, Ferentz says Huskers ‘turning the corner’ under second-year coachWASHINGTON (AP) — Three American citizens imprisoned for years by China have been released and are returning to the United States, the White House said Wednesday, announcing a diplomatic agreement with Beijing in the final months of the Biden administration. The three are , all of whom had been designated by the U.S. government as wrongfully detained by China. had been facing a death sentence on drug charges while and were imprisoned on espionage charges. “Soon they will return and be reunited with their families for the first time in many years,” the White House said in a statement. The release comes just two months after China freed David Lin, who had spent nearly 20 years behind bars after being convicted of contract fraud. U.S.-China relations have been roiled for years over major disagreements between the world’s two largest economies on trade, human rights, the production of fentanyl precursors, security issues that include espionage and hacking, China’s aggressiveness toward Taiwan and its smaller neighbors in the South China Sea, and Beijing’s support for Russia’s military-industrial sector. The release of Americans deemed wrongfully detained in China has been a top agenda item in each conversation between the U.S. and China, and Wednesday’s development suggests a willingness by Beijing to engage with the outgoing Democratic administration before Republican President-elect Donald Trump’s return to the White House in January. Trump took significant actions against China on trade and diplomacy during his first term. He has pledged to continue those policies in his second term, leading to unease among many who fear that an all-out trade war will greatly affect the international economy and could spur potential Chinese military action against Taiwan. Still, the two countries have maintained a dialogue that has included a partial restoration of military-to-military contacts. President Joe Biden and Chinese leader Xi Jinping met this month to discuss potential improvements. In a separate but related move, the State Department on Wednesday lowered its travel warning to China to “level two,” advising U.S. citizens to “exercise increased caution” from the norm when traveling to the mainland. The alert had previously been at “level three,” telling Americans they should “reconsider travel” to China in part because of the “risk of wrongful detention” of Americans. The new alert removes that wording but retains a warning that the Chinese government “arbitrarily enforces local laws, including exit bans on U.S. citizens and citizens of other countries, without fair and transparent process under the law.” The Biden administration had raised the cases of the detained Americans with China in multiple meetings over the past several years, including this month when Biden spoke to Xi on during the in Peru. Politico was first to report the men’s release, which it said was part of a prisoner swap with the U.S. The White House did not immediately confirm that any Chinese citizens had been returned home. Li, a Chinese immigrant who started an export business in the U.S., was detained in September 2016 after flying into Shanghai. He was placed under surveillance, interrogated without a lawyer and accused of providing state secrets to the FBI. A U.N. working group called his 10-year prison sentence arbitrary and his family said the charges were politically motivated. to life in prison on spying charges. He was detained in 2021, by the local bureau of China’s counterintelligence agency in the southeastern city of Suzhou after China had closed its borders and imposed tight domestic travel restrictions and social controls to fight the spread of COVID-19. After Leung's sentencing, — though without citing specific cases — that Americans reconsider traveling to China because of arbitrary law enforcement and exit bans and the risk of wrongful detentions. Swidan had been jailed for 12 years on a drug charge and, along with Li and Leung, had considered by the State Department to be wrongfully detained.
Key nations raced Saturday to salvage UN climate talks after the poorest countries pushed back angrily for more than $300 billion a year in help from historic wealthy emitters. More than a day past the scheduled conclusion of two days of COP29 talks, host Azerbaijan urged bleary-eyed delegates to seek consensus to avoid failure. "I know that none of us want to leave Baku without a good outcome," COP president Mukhtar Babayev told a late-night session, urging all nations to "bridge the remaining divide". Developing power Brazil pleaded for at least some progress and said it would seek to build on it when it leads COP30 next year in the Amazon gateway of Belem. "After the difficult experience that we're having here in Baku, we need to reach some outcome that is minimally acceptable in line with the emergency we're facing," Brazil's environment minister Marina Silva told delegates. A number of nations have accused Azerbaijan, an authoritarian oil and gas exporter, of lacking the experience and will to meet the moment, as the planet again sets record temperatures and faces rising deadly disasters. Small island nations threatened by rising seas and impoverished African states on Saturday angrily stormed out of a meeting with Azerbaijan, saying their concerns had been ignored. The European Union, United States and other wealthy countries met directly with poorer nations to work out final details, with both blocs also concerned at efforts led by Saudi Arabia to water down calls from last year's summit to phase out fossil fuels. "If we don't do it, people at home -- in every home across the world -- would say, why did you not get an agreement? Because I believe we can," Irish climate minister Eamon Ryan told AFP. A draft of the final text seen by AFP proposes that rich nations raise to $300 billion a year by 2035 their commitment to poorer countries to fight climate change. It is up from $100 billion now provided by wealthy nations under a commitment set to expire -- and from $250 billion proposed in a draft Friday. That offer was slammed as offensively low by developing countries, which have demanded at least $500 billion to build resilience against climate change and cut emissions. Sierra Leone's climate minister Jiwoh Abdulai, whose country is among the world's poorest, called the draft "effectively a suicide pact for the rest of the world". As staff at the cavernous and windowless stadium began closing down, diplomats rushed to meetings with one another, some ready with food and water in preparation for another late night. Panama's outspoken negotiator, Juan Carlos Monterrey Gomez, voiced anger at offers by rich countries but warned not to repeat the failure of COP15 in Copenhagen in 2009. "I'm sad, I'm tired, I'm disheartened, I'm hungry, I'm sleep-deprived, but there is a tiny ray of optimism within me because this cannot become a new Copenhagen," he told reporters. UK Energy Secretary Ed Miliband said the revised offer of $300 billion was "a significant scaling up" of the existing pledge by developed nations, which also count the United States, EU and Japan among their ranks. Climate activists shouted "shame" as US climate envoy John Podesta walked the halls. "Hopefully this is the storm before the calm," he said. Wealthy nations say it is politically unrealistic to expect more in direct government funding. Donald Trump, a sceptic of both climate change and foreign assistance, returns to the White House in January and a number of other Western countries have seen right-wing backlashes against the green agenda. The draft deal posits a larger overall target of $1.3 trillion per year to cope with rising temperatures and disasters, but most would come from private sources. Ali Mohamed, the Kenyan chair of the African Group of Negotiators, told AFP: "No deal is better than a bad deal." South African environment minister Dion George, however, said: "I think being ambitious at this point is not going to be very useful." "What we are not up for is going backwards or standing still," he said. "We might as well just have stayed at home then." The US and EU have wanted newly wealthy emerging economies like China -- the world's largest emitter -- to chip in. China, which remains classified as a developing nation under the UN framework, provides climate assistance but wants to keep doing so on its own voluntary terms. The EU and other countries have also tussled with Saudi Arabia over including strong language on moving away from fossil fuels, which negotiators say the oil-producing country has resisted. "We will not allow the most vulnerable, especially the small island states, to be ripped off by the new, few rich fossil fuel emitters," said German Foreign Minister Annalena Baerbock. bur-np-sct/lth/giv
None
Ranchi: “Ek hi naara, Hemant dobara” -- this slogan coined by the Jharkhand Mukti Morcha (JMM) for the state Assembly elections has resonated triumphantly in the state as the four-party alliance led by Hemant Soren has not only retained power but also set two historic records in Jharkhand's 24-year political history. First, this marks the first time a government has been re-elected for a second consecutive term. Second, no alliance had ever surpassed the milestone of winning 50 seats until now. Official figures from the Election Commission show the JMM-Congress-RJD-CPI(ML) alliance will secure about 55 seats in the 81-member assembly. About The game Changer In This Record-Breaking Win For JMM The game changer in this record-breaking win for the JMM is the Hemant Soren government’s Maiya Samman Yojana, launched in August this year. Under the scheme, Rs 1,000 is transferred monthly to the accounts of 57 lakh women aged 18 to 50 years. This initiative resonated deeply with women voters, who overwhelmingly supported the Soren-led government. Women outvoted men in 68 of the 81 assembly constituencies, with their total turnout exceeding men’s by 5,51,797 votes in a record voter turnout of 1.76 crore. Acknowledging this support, Hemant Soren expressed gratitude to women voters after the final phase of polling on November 20. On social media, he wrote, “Our Maiya has blessed us in historic numbers for dignity, respect, and rights.” Apart from Maiya Samman Yojna what other factors worked for Hemant Soren included waiving overdue electricity bills for about 37 lakh defaulters and farmers’ loan waivers of up to Rs 2 lakh. These measures particularly benefited rural areas, contributing to an unprecedented voter turnout in villages. Kalpana Soren Emerges As A Political Force In Jharkhand Assembly Elections 2024 Kalpana Soren, Hemant Soren’s wife, emerged as a political force during this campaign. Entering politics after Hemant Soren faced legal troubles earlier this year, Kalpana addressed 105 election rallies as the alliance's star campaigner. Her relatable style and charisma helped JMM appeal to urban voters, a notable shift for a party traditionally rooted in rural constituencies. Her rapid rise has been likened to a political comet, earning her widespread recognition. BJP, on the other hand, launched an aggressive campaign accusing JMM of corruption, even terming him and Kalpana Soren ‘Bunty and Babli’. The tribal community, a key constituency in Jharkhand, largely stood by JMM. BJP’s attempts to court them failed, partly due to tribal anger over Hemant Soren’s imprisonment and dissatisfaction with BJP's policies. The BJP’s focus on issues like alleged Bangladeshi infiltration in the Santhal Pargana region also failed to gain traction among the masses. Their decision to rely heavily on out-of-state leaders like Assam Chief Minister Himanta Biswa Sarma and Union Minister Shivraj Singh Chouhan backfired, as the election became a direct contest between Hemant Soren and Himanta. Jharkhand voters rejected the BJP’s strategy, branding Sarma an outsider, seeing the entire electoral battle as Hemant vs Himanta. With the blessing of Maiya and Kalpana Soren’s dynamic campaigning, JMM has not only shattered historical records but also reinforced its image as a people's party. This victory cements Hemant Soren's leadership and sets a transformative precedent in Jharkhand's political narrative. (Except for the headline, this article has not been edited by FPJ's editorial team and is auto-generated from an agency feed.)
Paralympics New Zealand (PNZ) is pleased to announce there-election of Paralympian#195 Anna Grimaldi and election of Paralympian#158 Adam Hall and Paralympian#211 Danielle Aitchison to the PNZ Athletes’Council. The PNZ Athletes’ Council was establishedin 2021 to enable representation of New Zealand Paralympiansand Para athletes and enable greater athlete participationand voice within the Paralympic Movement within New Zealandand internationally. Anna, Danielle and Adam will joinParalympian#189 Carl Murphy and Paralympian#225 Anna Taylor as members on the PNZ Athletes’Council. Eight candidates put forward their names forelection and we thank everyone for their interest in seekingelection to the PNZ Athletes’ Council. Para athleteAnna Grimaldi, a three-time Paralympic gold medallist, said:“I’m super happy to be able to continue my work with thePNZ Athletes’ Council for this next term. It’s been aprivilege to play my part in amplifying the athletes’voice and I can’t wait to maintain the momentum leadinginto the Milano Cortina 2026 Paralympic Winter Games and LA2028 Paralympic Games. I love the athletes we have here inNew Zealand, and I want to make sure they are wellrepresented.” Danielle Aitchison, a winner of fourPara athletics medals at the Paralympic Games, said: “I amdeeply honoured to be elected to the PNZ Athletes’Council. This role holds significant meaning for me, as itprovides an opportunity to be a voice within the ParalympicMovement – not only for all Para athletes but also toensure that challenges I have faced are not repeated. Sporthas been a vital part in my life, and I am committed tofostering a safe and enjoyable environment for every Paraathlete who chooses to participate.” Adam Hall, afive-time Paralympic Para alpine skiing medallist, said:“I am incredibly honoured to have been successfullyelected to the PNZ Athletes’ Council. I look forward tocollaborating with the great cohort on the Council and usingmy voice to help encourage and elevate our Paralympians andPara athletes and ensure our sport continues tothrive.” Outgoing Chair Paralympian#213 Sarah Ellington adds of her three years in therole. “I am sad to be stepping down as Chair from the PNZAthletes’ Council but it has been a great three years inthe role. I am looking forward to seeing what the newCouncil will achieve, and I wish everyone all the best inmaking the most of this amazing opportunity.” Otheroutgoing council members include Paralympian#148 Michael Johnson and Paralympian#202 Jacob Phillips. Greg Warnecke said: “We areexcited to welcome Anna back to the PNZ Athletes’ Councilfollowing her re-election and both Danielle and Adam to theCouncil for the first time. The trio will provide fantasticinsights from their rich experiences, which will help guideand inform our work as an organisation in the future. Fromall at PNZ we would also like to extent our thanks for thevaluable contribution played by outgoing Council members;Sarah, Michael and Jacob.” The new Chair and ViceChair will be elected next year. For furtherinformation, go toparalympics.org.nz/about/pnz-athletes-council/ NZ ParalympicTeam strives to challenge perceptions towards disability,showcasing high performance athletes who prove anything ispossible. Since Tel Aviv 1968 Paralympic Games, 237New Zealand Paralympians have been part of New ZealandParalympic Teams competing at 27 Paralympic Games (15 summerand 12 winter) winning a staggering 245 medals (210 insummer and 35 in winter). Paralympics New Zealand isthe National Paralympic Committee (NPC) for New Zealand. Weare a charity and our overall vision is ‘Transforminglives through Para sport’. As a member of theInternational Paralympic Committee (IPC), we are part of aworldwide social change movement, which uses the power ofsport to positively influence community perceptions ofdisabled people and to promote a more diverse and inclusivesociety. To do this, we support and celebrate theachievements of Para athletes at international and nationalcompetitions all year round. Every two years, we lead NewZealand teams to the Paralympic Games. We also work in thelocal community to advocate for sport to become moreaccessible for disabled people and to support the creationof more systems and programmes to enable participation inPara sport. Our funding comes from a mix of publicdonations, fundraisers, philanthropic partners, commercialpartners, plus government and community grants, whichtogether make our Para sport, community and advocacyprogrammes possible. To find out more about us, pleasevisit aboutus To support Paralympics New Zealand click here Jointhe conversation on Facebook,LinkedInand Instagram.A frustrated Leicester City boss Steve Cooper confirmed he will write to the PGMOL after his side's 2-1 loss to Chelsea. Cooper also bit his tongue when discussing referee Andy Madley's performance to avoid getting into further trouble. The Foxes boss was adamant his side should have had a penalty in the second half when Chelsea defender Levi Colwill looked to have brought down Stephy Mavididi . However, Madley did not award it and VAR opted not to intervene. Leicester did have a penalty in second half stoppage time when Bobby De Cordova-Reid was fouled by Romeo Lavia , although it took a VAR review to get there. Leigh Doughty, who began the game as fourth official but took over linesman duties from Mark Scholes at half-time after the latter picked up an injury , initially flagged Reid to be offside. But replays showed the Leicester forward was clearly onside as Madley was told to award a penalty. Speaking to talkSPORT's Sam Matterface after the contest, Cooper, who was booked by Madley for his protests in the second half, conceded he felt the club had to take extreme measures to get the PGMOL's attention after the official's performance. "I think the club needs to, and they will, they will to be fair because I'm not saying that we're not, but in this moment we have got to officially write things or pick up the phone and go, 'Come on, what's going on here,'" Cooper told talkSPORT. "The last thing the PGMOL needed this week is things like that. It's no good for anybody. "Sometimes, they can go for you and against you. But it's the last thing they need in the first Premier League game after the international break. "Everybody is talking more about the decisions than the actual game, which is always a good indicator of how the game's been refereed. Cooper added: "We had him (Madley) at Palace as well for the VAR. "I won't say anything that's going to get me into trouble. But we've had some bad luck with him this year. That's all I'll say on it." Madley was indeed the VAR when Leicester and Crystal Palace met in the fourth game of the Premier League season. Palace striker Jean-Philippe Mateta scored a 92nd-minute equaliser from the spot to rescue his side from 2-0 down as the contest ended 2-2. However, Cooper was left furious over Mateta's first goal as it was initially flagged for offside, only for VAR to overturn the decision and award it. But Cooper believed VAR had used the wrong freeze-frame to decide whether Mateta was off-side as images shared on social media proved the Foxes boss was right to be angry. Leicester met with the PGMOL two days after but it was explained to them no human error was made and the correct frame was used to decide whether Mateta was off-side or not. However, Cooper held nothing back during his press conference in the days after. "We're over it now, it was an awful human error that we believe has been hidden a little bit," Cooper said. "We have seen different images that show he clearly was offside, but unfortunately they froze it at the wrong time and he was deemed to be onside. Everything that has been seen has been a false image. "On Monday we showed the Premier League with clear footage that actually the game was stopped at the wrong time. "Decisions go against you whether it's in-game or VAR and we've had a massive error go against us. We don't want it to go under the radar because I don't think that's right for the players or for the supporters. "Errors like that shouldn't happen and it's why we're changing to the semi-automated system. We felt very let down by it. We needed to stand up for the club and tell the Premier League what we thought."Legal awareness event to boost Palamu cops’ investigative skills
Islanders hope to win third straight when Kings roll into townKing scores 19 as Northeastern takes down FGCU 59-55
China's anti-monopoly regulator announced Monday that it was investigating potential violations of antitrust law by Nvidia , the U.S. company that makes a vast majority of the computer chips that power artificial intelligence systems. The inquiry, a rare move by Beijing, comes a week after the Biden administration expanded curbs on the sale of advanced U.S. technology to China. In the days since, the Chinese government announced that it would ban the export of several rare minerals to the United States and imposed sanctions on more than a dozen U.S. defense firms and defense industry executives. Together, the moves by Beijing signal its willingness to engage in supply chain warfare as the policy contest over trade and the control of technology escalates between the world's two largest economies. The battle has made AI chips into one of the world's most sought-after technologies, and Nvidia has cornered the market, accounting for 90% of global sales by the end of last year. Nvidia's dominance helped it become one of the most valuable companies in the world over the past year. China's State Administration for Market Regulation said Monday that it was investigating Nvidia for violating commitments made during its acquisition of Mellanox Technologies, a company that makes computer networking equipment. The Chinese regulator approved Nvidia's acquisition of the company in 2020 with conditions to prevent anti-competitive practices and ensure supplies to China. Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program Legal Complete Guide to AI Governance and Compliance By - Prince Patni, Software Developer (BI, Data Science) View Program Data Analysis Animated Visualizations with Flourish Studio: Beginner to Pro By - Prince Patni, Software Developer (BI, Data Science) View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development JavaScript Essentials: Unlock AI-Driven Insights with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship From Idea to Product: A Startup Development Guide By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Artificial Intelligence(AI) Learn InVideo AI: Create Videos from Text Easily By - Prince Patni, Software Developer (BI, Data Science) View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Finance AI and Generative AI for Finance By - Hariom Tatsat, Vice President- Quantitative Analytics at Barclays View Program Finance Value and Valuation Masterclass By - CA Himanshu Jain, Ex McKinsey, Moody's, and PwC, Co - founder, The WallStreet School View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Finance Tally Prime & GST Accounting: Complete Guide By - CA Raj K Agrawal, Chartered Accountant View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Web Development Django & PostgreSQL Mastery: Build Professional Web Applications By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Crafting a Powerful Startup Value Proposition By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Nvidia said in a statement that it was "happy to answer" questions from China's regulators. "We work hard to provide the best products we can in every region and honor our commitments everywhere we do business," the statement said. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories As the Biden administration has progressively tightened restrictions on Nvidia's chip sales to China, the company has responded by offering less powerful versions of its chips to the Chinese market. Officials in Washington, in trying to prevent Chinese companies from buying advanced chips and the machines to make them, say that the technology is essential not just for smartphones and chatbots but also for military superiority. Chinese tech companies have resorted to stockpiling the chips, while also turning to smugglers and front companies to secure supplies. At the same time, Beijing is pouring large sums of money into its own chip companies in an attempt to make its tech sector less reliant on foreign technology.
New Delhi: Prime Minister Narendra Modi on Saturday said the latest round of elections has endorsed the message of development and defeated the politics of lies and betrayal propounded by the Congress and its allies. Addressing a gathering at the Bharatiya Janata Party (BJP) headquarters here, Modi said divisive forces, negative politics and dynasticism have been defeated in the Maharashtra election and bypolls in various states. He said the people of Maharashtra have voted for stability and taught a lesson to those who tried to create instability. The prime minister asserted that the message from the Maharashtra election is that of unity and it is also an endorsement of the "ek hai toh safe hai" slogan. Modi also said he bows down before the people of Jharkhand and that the BJP will work more zealously for the development of the state. "'Ek hai toh safe hai' has become the 'maha-mantra' for the entire nation and it has punished those who wanted to divide the country on caste and religious lines," he said, adding that all sections of the society have voted for the BJP. "The Congress and its ecosystem had thought that by spreading lies in the name of the Constitution, they could divide the Scheduled Castes (SCs), Scheduled Tribes (STs) and Other Backward Classes (OBC) in small groups. This is a solid slap on their faces," he said. "People have made divisive forces bite the dust. The Congress and its allies have failed to grasp the changed realities of the country's mood," the prime minister added. He asserted that voters do not want instability and they believe in nation first and do not like those dreaming about "chair first". The voters in Maharashtra also evaluated Congress on the basis of the false promises made in other states like Karnataka, Telangana and Himachal Pradesh, he added. "Neither their false promises nor their dangerous agenda worked in Maharashtra," Modi said. The prime minister said the Maharashtra election also shows that only one Constitution will work in India and that was given to the people of the country by B R Ambedkar. The Congress and its allies were again trying to create a wall of Article 370 of the Constitution in Jammu and Kashmir, he said. "I want to say this to the Congress and its allies that no force in the world can bring back Article 370 and insult our Constitution," Modi said. He said the Congress and its allies were double-faced on various issues, including the Wafq Board. (PTI)